https://www.eurekalert.org/pub_releases/2018-03/uoz-rfs030718.php A trauma to the spinal cord, quickly leads to a progressive loss of nerve tissue. This not only affects the injured area, but over time affects also other parts of the spinal cord and even the brain…
Author Archives: clientekdev
Revolutionary Robotic Treatment For Patients With Spinal Cord Injuries Now Available In United States
https://globenewswire.com/news-release/2018/03/02/1414086/0/en/Revolutionary-Robotic-Treatment-For-Patients-With-Spinal-Cord-Injuries-Now-Available-In-United-States.html Brooks Rehabilitation, an industry leader in post-acute physical rehabilitation, announced today its partnership with Japanese medical and social innovation company, CYBERDYNE, INC., to introduce and make available the world’s first advanced robotic treatment device that has been shown to improve a patient’s ability to walk…
Amazing Video Shows Paralyzed Woman Walking Again After Adult Stem Cell Treatment
http://www.lifenews.com/2018/02/05/amazing-video-shows-paralyzed-woman-walking-again-after-adult-stem-cell-treatment/ Today the Charlotte Lozier Institute announced the release of its latest testimonial video at StemCellResearchFacts.org, a project of the Washington, D.C.-based research and policy group that serves as the education arm of Susan B. Anthony List. The video revisits Laura Dominguez-Tauer, a young woman with a spinal cord injury whose story was first toldContinue reading “Amazing Video Shows Paralyzed Woman Walking Again After Adult Stem Cell Treatment”
U of L launches groundbreaking study on spinal cord injuries
http://www.wdrb.com/story/37203362/u-of-l-launches-groundbreaking-study-on-spinal-cord-injuries The U.S. Food and Drug Administration approved a new University of Louisville School of Medicine study, in which it will test epidural stimulation for people who are paralyzed…
New trial aiming to repair injured spinal cords gives new hope to paralysed Australians
http://www.smh.com.au/national/new-trial-aiming-to-repair-injured-spinal-cords-gives-new-hope-to-paralysed-australians-20171130-gzvzwe.html Anne-Marie Howarth was riding her motorcycle in the Blue Mountains when she went too fast on a bend, crashed into a barrier and “squashed” her spine, leaving her paralyzed from the lower chest down…
A decade after stem cell feat, research ramps up
http://host.madison.com/wsj/news/local/health-med-fit/a-decade-after-stem-cell-feat-research-ramps-up/article_f434ac73-0258-53c9-ab9d-f17a0726ad99.html In his UW-Madison lab, Su-Chun Zhang discovered a likely cause of ALS, the deadly neurological disorder also known as Lou Gehrig’s disease, after turning skin cells from ALS patients into stem cells. A protein error in cellular structures called neurofilaments, which transport chemicals that allow muscles to move, leads to paralysis in at leastContinue reading “A decade after stem cell feat, research ramps up”
Regenerative Medicine Restores Movement After Paralysis
http://www.newswise.com/articles/regenerative-medicine-restores-movement-after-paralysis Twelve-month data from spinal cord injury trial shows two-thirds of subjects recovered two or more motor levels Newswise — Four of six people with paralyzing spinal cord injuries who were treated with a new cell therapy have recovered two or more motor levels on at least one side, new study results show.
Asterias Announces Two Significant Developments for Spinal Cord Injury Program
https://globenewswire.com/news-release/2017/10/02/1138619/0/en/Asterias-Announces-Two-Significant-Developments-for-Spinal-Cord-Injury-Program.html FREMONT, Calif., Oct. 02, 2017 (GLOBE NEWSWIRE) — Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company pioneering the field of regenerative medicine, today announced new 12-month data from the first efficacy cohort in the company’s ongoing Phase 1/2a SCiStar study designated to evaluate safety and efficacy of AST-OPC1…
Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study
https://globenewswire.com/news-release/2017/08/23/1091407/0/en/Asterias-Biotherapeutics-Opens-Additional-Clinical-Site-for-AST-OPC1-SCiStar-Study.html Source: Asterias Biotherapeutics FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) — Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Washington University School of Medicine in St. Louis, MO, has been added as a clinical site in the company’s ongoing SCiStar Phase 1/2a clinical trial ofContinue reading “Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study”
Nerve fibers regenerated with molecular mix
http://www.medicalnewstoday.com/articles/319011.php By Ana Sandoiu Damage to a neuron’s axon, or nerve fiber – the ‘long tail’ that sends signals from the cell body – is a key element of spinal cord injury. Scientists may have found a way to regrow axons – a crucial part of a neuron also known as a nerve fiber –Continue reading “Nerve fibers regenerated with molecular mix”
NEW SPINAL CORD INJURY REPAIR COMPANY LAUNCHED
https://ryortho.com/breaking/new-spinal-cord-injury-repair-company-launched/ Elizabeth Hofheinz, M.P.H., M.Ed. • Fri, August 18th, 2017 Print this article Based on an innovative technology from Yale University which has shown promise to grow nerve fibers naturally and restore all facets of nerve function, a new company, ReNetX Bio (formerly known as Axerion Therapeutics), has been launched. ReNetX Bio is focused onContinue reading “NEW SPINAL CORD INJURY REPAIR COMPANY LAUNCHED”
Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial
http://www.nasdaq.com/press-release/asterias-enrolls-first-patient-in-final-cohort-of-scistar-clinical-trial-20170809-00443 By GlobeNewswire, August 09, 2017, 07:00:00 AM Enrollment for entire SCiStar study expected to be completed by end-2017 FREMONT, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) — Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment and dosing of the first patient in the fifth and finalContinue reading “Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial”
Nipro closing in on stem cell cure for spinal cord injuries
https://asia.nikkei.com/Tech-Science/Science/Nipro-closing-in-on-stem-cell-cure-for-spinal-cord-injuries OSAKA — Medical equipment maker Nipro could commercialize next year a stem-cell-based treatment seen allowing people with spinal cord injuries to walk again. The Osaka-based company has carried out joint research with Sapporo Medical University since 2014. They recently found success in trials where stem cells harvested from bone marrow and increased are returnedContinue reading “Nipro closing in on stem cell cure for spinal cord injuries”
Surgery can prompt sensory nerves to ‘sprout’ fresh connections to spinal cord
http://www.couriermail.com.au/technology/science/surgery-can-prompt-sensory-nerves-to-sprout-fresh-connections-to-spinal-cord/news-story/e22d49b3772d03e7f008524abf8d53a8 Jamie Seidel, News Corp Australia Network THE quest to repair spinal cord injuries is a medical holy grail. Now, we’re beginning to understand how it could be done. And the fix may already be in our own bodies. A study by Kings College London examined a new surgery technique capable of reconnecting complex sensoryContinue reading “Surgery can prompt sensory nerves to ‘sprout’ fresh connections to spinal cord”
Scholar Rock and the Miami Project to Cure Paralysis Present Preclinical Data Demonstrating Therapeutic Potential of SRK-015 in Spinal Cord Injury at 35th Annual National Neurotrauma Symposium
http://pipelinereview.com/index.php/2017071165199/Small-Molecules/Scholar-Rock-and-the-Miami-Project-to-Cure-Paralysis-Present-Preclinical-Data-Demonstrating-Therapeutic-Potential-of-SRK-015-in-Spinal-Cord-Injury-at-35th-Annual-National.html CAMBRIDGE, MA, USA I July 10, 2017 I Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target growth factors in the disease microenvironment, today announced the presentation of data from its SRK-015 antibody program, in collaboration…